Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | BMY | AMGN | GILD | REGN |
| Company | Vericel Corporation | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 45.49 | 47.39 | 273.45 | 67.47 | 911.09 |
| High | 45.76 | 47.50 | 274.35 | 67.90 | 915.00 |
| Low | 44.50 | 44.37 | 267.24 | 65.09 | 876.75 |
| Last | 45.45 | 44.70 | 269.38 | 65.27 | 890.68 |
| Change | -0.66 | -4.16 | -3.63 | -1.81 | -15.86 |
| % Change | -1.43% | -8.51% | -1.33% | -2.70% | -1.75% |
| Volume | 258,200 | 45,069,000 | 1,794,000 | 15,171,900 | 576,500 |
| 20-Day Average Volume | 353,065 | 12,858,680 | 2,149,590 | 6,861,755 | 454,910 |
| Previous Close | 46.11 | 48.86 | 273.01 | 67.08 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.44 | 49.94 | 270.70 | 68.68 | 922.51 |
| 20-Day Raw Stochastic | 28.81% | 3.27% | 31.20% | 2.05% | 14.81% |
| 20-Day Relative Strength | 45.62% | 28.31% | 44.80% | 28.32% | 34.96% |
| Weighted Alpha | +44.56 | -34.75 | +9.12 | -23.73 | +11.12 |
| Today's Opinion | 56% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.63% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | -0.37% since 04/18/24 |
| Low | 42.38 on 04/19/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 47.14 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -5.19% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -7.33% since 03/25/24 |
| Low | 42.38 on 04/19/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 53.05 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +6.69% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -6.13% since 01/25/24 |
| Low | 41.58 on 02/07/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 876.75 on 04/25/24 |
| High | 53.05 on 04/01/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +32.35% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +11.75% since 10/25/23 |
| Low | 32.28 on 11/09/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 769.19 on 10/27/23 |
| High | 53.05 on 04/01/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,230,802 | 99,027,448 | 146,436,016 | 83,519,768 | 99,503,640 |
| Shares Outstanding, K | 48,380 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 197,520,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -3,180,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 65,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | 12,990,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.71 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 02/29/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/08/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 24.14 |